Johnson & Johnson JNJ:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:27 PM EDT
148.87quote price arrow up+0.29 (+0.20%)
Volume
2,440,788
52 week range
143.13 - 175.97
Loading...
  • Open149.38
  • Day High149.73
  • Day Low148.69
  • Prev Close148.58
  • 52 Week High175.97
  • 52 Week High Date08/10/23
  • 52 Week Low143.13
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap358.282B
  • Shares Out2.41B
  • 10 Day Average Volume8.35M
  • Dividend4.96
  • Dividend Yield3.33%
  • Beta0.53
  • YTD % Change-5.05

KEY STATS

  • Open149.38
  • Day High149.73
  • Day Low148.69
  • Prev Close148.58
  • 52 Week High175.97
  • 52 Week High Date08/10/23
  • 52 Week Low143.13
  • 52 Week Low Date04/18/24
  • Market Cap358.282B
  • Shares Out2.41B
  • 10 Day Average Volume8.35M
  • Dividend4.96
  • Dividend Yield3.33%
  • Beta0.53
  • YTD % Change-5.05

RATIOS/PROFITABILITY

  • EPS (TTM)6.69
  • P/E (TTM)22.26
  • Fwd P/E (NTM)14.09
  • EBITDA (TTM)31.292B
  • ROE (TTM)24.23%
  • Revenue (TTM)85.648B
  • Gross Margin (TTM)69.57%
  • Net Margin (TTM)19.93%
  • Debt To Equity (MRQ)48.03%

EVENTS

  • Earnings Date07/17/2024(est)
  • Ex Div Date05/20/2024
  • Div Amount1.24
  • Split Date-
  • Split Factor-

Related Video

Wednesday’s rapid fire: AMD, Johnson & Johnson, CVS Health, Super Micro and Pinterest
VIDEO1:5101:51
Wednesday’s rapid fire: AMD, Johnson & Johnson, CVS Health, Super Micro and Pinterest

Profile

MORE
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...
Joaquin Duato
Chairman of the Board, Chief Executive Officer
Joseph Wolk
Chief Financial Officer, Executive Vice President
Tim Schmid
Executive Vice President, Worldwide Chairman of MedTech
Elizabeth Forminard
Executive Vice President, General Counsel
John Reed M.D., Ph.D.
Executive Vice President - Innovative Medicine, Research and Development
Address
One Johnson & Johnson Plaza
New Brunswick, NJ
08933
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
129.31+1.75+1.37%
ABBV
AbbVie Inc
162.28-0.45-0.28%
AZN
AstraZeneca PLC
76.11+0.34+0.46%
RHHBY
Roche Holding AG
30.41+0.31+1.05%
NVS
Novartis AG
98.97+1.24+1.27%